The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings
Biotech stocks saw muted sentiment in the holiday-shortened week ending July 5 af.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings
Biotech stocks saw muted sentiment in the holiday-shortened week ending July 5 after a strong rebound in the later part of the previous week. Activity was light, although news on clinical trial readouts continued to flow. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs
Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and earnings all on offer. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs
Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and&nb.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results an.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More
A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. Here's a look at the upcoming week's catalytic events. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More
A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. He.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs
The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. Conferences Alzheimer's Association In.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs
The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs
Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NA.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs
Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs
After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs
After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S. read more.....»»